共 50 条
- [1] Clinical relevance and management of drug-related QT interval prolongation [J]. PHARMACOTHERAPY, 2003, 23 (07): : 881 - 908
- [4] FDA weighs communicating drug-related risk to patients [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (06): : 515 - 515
- [10] The impact of drug-induced QT interval prolongation on drug discovery and development [J]. Nature Reviews Drug Discovery, 2003, 2 : 439 - 447